Economic evaluation of the new oral anticoagulants for the prevention of thromboembolic events: a cost-minimization analysis

Economic evaluation of the new oral anticoagulants for the prevention of thromboembolic events: a cost-minimization analysis

ABSTRACT CONTEXT AND OBJECTIVE: Randomized clinical trials have shown that the new oral anticoagulants have at least similar impact regarding reduction of thromboembolic events, compared with warfarin, with similar or improved safety profiles. There is little data on real costs within clinical pra...

Full description

Bibliographic Details
Main Authors: Milena Soriano Marcolino, Carisi Anne Polanczyk, Ana Carolina Caixeta Bovendorp, Naiara Silveira Marques, Lilian Azevedo da Silva, Cintia Proveti Barbosa Turquia, Antonio Luiz Ribeiro
Format: Article
Language:English
Published: Associação Paulista de Medicina
Series:São Paulo Medical Journal
Subjects:
Anticoagulants
Warfarin
Atrial fibrillation
Costs and cost analysis
Public health
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802016000400322&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802016000400322&lng=en&tlng=en

Similar Items